Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 488 Leukemia 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 198 Lymphoma 133 Myelodysplastic Syndromes 95 Burkitt Lymphoma 77 Lymphoma, Non-Hodgkin 74 Leukemia, Monocytic, Acute 74 Congenital Abnormalities 73 Leukemia, Myelomonocytic, Acute 71 Leukemia, Erythroblastic, Acute 66 Lymphoma, Large B-Cell, Diffuse 65 Leukemia, Megakaryoblastic, Acute 63 Recurrence 59 Lymphoma, Mantle-Cell 58 Lymphoma, Follicular 42 Hodgkin Disease 40 Leukemia, Myelomonocytic, Chronic 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 34 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, B-Cell, Marginal Zone 21 Leukemia, Myeloid, Chronic-Phase 21 Multiple Myeloma 20 Leukemia, Eosinophilic, Acute 19

Interventions

Doxorubicin 15 Echocardiography 13 Exercise 7 Dexrazoxane 7 Cyclophosphamide 7 Trastuzumab 6 Electrocardiography 6 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Docetaxel 3 Cisplatin 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Tablets 2 Social Determinants of Health 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Chemotherapy, Adjuvant 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡